Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Board Meeting to Approve Q1 FY27 Results
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 22 Jul 2026, 03:30 PM IST · BSE ID: 2438a4c1-b712-4759-b2ec-54c3db927230
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on July 25, 2026, to review and approve its financial results for the first quarter.
🤖 AI Summary
- Oxygenta Pharmaceutical Ltd Board will convene a meeting on Saturday, July 25, 2026.
- The Board will consider and approve un-audited financial results for the quarter ended June 30, 2026.
- A Limited Review Report for the quarter ended June 30, 2026, will also be presented for approval.
- The meeting is being held as per Regulation 29 read with Regulation 33 of SEBI (LODR) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results for the quarter ended June 30, 2026, which will provide insight into the company's performance.
🔍
Management Signal
The scheduled Board Meeting signals management's adherence to regulatory requirements for timely disclosure of financial results.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 financial results — check revenue and profit for quarter ended June 30, 2026.
Any additional Board decisions made during the July 25, 2026, meeting.
Company disclosures regarding the Limited Review Report findings.
LOW RISK
This filing is a standard procedural announcement for a board meeting to approve quarterly results.
💡 Investor Takeaway
Oxygenta Pharmaceutical Ltd has scheduled a Board Meeting for July 25, 2026, to consider and approve its un-audited financial results and Limited Review Report for the quarter ended June 30, 2026. This is a routine procedural announcement.
❓ Frequently Asked Questions
When is the Board Meeting of Oxygenta Pharmaceutical Ltd scheduled?
The Board Meeting of Oxygenta Pharmaceutical Ltd is scheduled for Saturday, July 25, 2026.
What financial results will be considered at the Oxygenta Pharmaceutical Ltd Board Meeting?
The Board will consider and approve the un-audited financial results for the quarter ended June 30, 2026.
What else is on the agenda for the Oxygenta Pharmaceutical Ltd Board Meeting?
The agenda also includes considering and approving the Limited Review Report for the quarter ended June 30, 2026, and any other business with the permission of the Chair.
Questions based on this BSE filing only. For information purposes.